Skip to main content
11 May 2025
Last updated:
Saturday 10 May 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
EU examines incentives for the pharma industry
Read more
The risks of therapeutic genome editing
Read more
Is an EU approval better than a hospital exemption?
Read more
MedNous Briefing - The European Medicine Agency's PRIME Scheme
Read more
The Trump impact on healthcare M&A
Read more
Global oncology has many first-in-class compounds
Read more
Britain looks to life outside the EU
Read more
Oncology drug approvals accelerate
Read more
Report from Singapore: Creating incentives for life science innovation
Read more
Hospital exemption: The debate heats up over local manufacture
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
4
Page
5
Page
6
Page
7
Current page
8
Page
9
Page
10
Page
11
Page
12
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form